Abstract

Dyslipidemia is a major contributor to the evolution of cardiovascular disease (CVD) among patients with type 2 diabetes mellitus (T2DM). There is a guideline recommendation to offer statin therapy to all T2DM patients between 40 to 75 years old for either primary or secondary CVD prophylaxis. Nevertheless, the suboptimal management of diabetic dyslipidemia in the Malaysian primary care settings has been reported. This study aimed to describe the statin therapy prescribing pattern among patients with T2DM, evaluate the appropriateness of statin therapy prescribing, and assess the level of achievement of the primary target (LDL-C) for diabetic dyslipidemia treatment.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call